March 2023

A new paradigm for managing data

March 17, 2023
Regeneron Pharmaceuticals, a biotechnology company that develops life-transforming medicines, found itself inundated with vast volumes of data during the peak of the covid-19 pandemic. In order to derive actionable information from these disparate data sets, which ranged from clinical trial data to real-time supply chain information, the company needed new ways to join and relate…

3 Stocks You’ll Thank Yourself Later for Buying in 2023

March 17, 2023
High-profile bank failures have exacerbated fresh volatility in the stock market. The central bank stands at policy crossroads, weighing recent strong economic data against jittery capital markets. Amid an uncertain…

Don’t use Sam Altman and AI hype in the same sentence

March 17, 2023

Hello, and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. Today, we’re celebrating Equity’s 6th birthday! Thankfully, it fell during the easiest, slowest news cycle we’ve had since the beginning of the grocery delivery wars and WeWork. Just kidding. Alex and Natasha […]

Don’t use Sam Altman and AI hype in the same sentence by Natasha Mascarenhas originally published on TechCrunch